癌变·畸变·突变 ›› 2007, Vol. 19 ›› Issue (2): 155-156.doi: 10.3969/j.issn.1004-616x.2007.02.022

• 检测研究 • 上一篇    下一篇

利拉萘酯致突变作用的研究

张耿月 周晓军 宋连生   

  1. 吉林省肿瘤防治研究所 长春 130012
  • 收稿日期:2006-03-31 修回日期:2006-11-25 出版日期:2007-03-30 发布日期:2007-03-30
  • 通讯作者: 张耿月

Mutagenicity Study on Liranaftate

ZHANG Geng_yue,ZHOU Xiao_jun, SONG Lian_sheng   

  1. Jilin Provincal Tumor Research Institute, Changchun
  • Received:2006-03-31 Revised:2006-11-25 Online:2007-03-30 Published:2007-03-30
  • Contact: ZHANG Geng_yue

摘要: 背景与目的: 研究利拉萘酯是否具有潜在的遗传危害。 材料与方法: 采用Ames试验、中国仓鼠肺细胞染色体畸变试验、小鼠骨髓微核试验对利拉萘酯的突变性进行研究。 结果: 利拉萘酯各剂量对中国仓鼠肺细胞的染色体无畸变作用;对小鼠骨髓嗜多染红细胞的微核率无增加作用;对4种试验菌株均未引起回变菌落数增加。 结论: 利拉萘酯在本试验的剂量范围内无致突变效应。

关键词: 利拉萘酯, 致突变性, 微核, Ames试验

Abstract: BACKGROUND & AIM: To explore the mutagenicity of Liranaftate. MATERIALS AND METHODS: The mutagenicity of liranaftate was tested by the micronucleus assay, chromosomal aberration test of CHL and the Ames assay. RESULTS: It was found that all of the tests that mentioned above were negative. CONCLUSION: Liranaftate had no mutagenicity in this test.

Key words: liranaftate, mutagenicity, micronucleus, Ames test

中图分类号: